सत्याधीशसत्याधीश
SatyaDheesh
India's Ground Truth Record
Pull to refresh
VOL. I · EST. 11.2025 
SatyaDheesh
सत्याधीश
India's Ground Truth Record
LIVE

Lyfius Pharma's ₹2,500 crore Penicillin-G facility to reduce India's import dependence

GS3Economy · S&T · Environment · Security· Industry, investment & MSMEs· Prelims·

Import substitution and PLI scheme impact: a relevant GS3 case study on pharmaceutical self-reliance.

Why in news

Nara Lokesh highlighted Lyfius Pharma's new Penicillin-G facility in Kakinada SEZ as a step toward reducing India's dependence on imported raw materials.

Background

Lyfius Pharma Private Limited invested ₹2,500 crore to establish a Penicillin-G facility in the Kakinada Special Economic Zone (SEZ). The facility has an annual production capacity of 1,500 tonnes and was inaugurated by PM Narendra Modi in October 2024.

Facts for Prelims

  • FactLyfius Pharma invested ₹2,500 crore in the Penicillin-G facility.
  • FactThe facility has an annual production capacity of 1,500 tonnes.
  • SchemeThe project was executed under the Production Linked Incentive (PLI) scheme.
  • PlaceThe facility is located in the Kakinada Special Economic Zone (SEZ).

Prelims practice question

With reference to the Lyfius Pharma Penicillin-G facility, consider the following statements:

  1. The facility was established in the Kakinada Special Economic Zone (SEZ).
  2. The facility has an annual production capacity of 2,500 tonnes.
  3. The project was executed under the Production Linked Incentive (PLI) scheme.

Which of the statements given above is/are correct?

  1. (a)2 only
  2. (b)3 only
  3. (c)1 and 3 only
  4. (d)1, 2 and 3
Show answer

Answer: (c) 1 and 3 only — Statements 1 and 3 are correct. Statement 2 is incorrect: The note states the annual production capacity is 1,500 tonnes.

For Mains

Q. Discuss how the Production Linked Incentive (PLI) scheme contributes to India's goal of achieving self-reliance in the pharmaceutical manufacturing sector.

Dimensions to cover in your answer

  • Supply chain resilience: Reducing vulnerability to global raw material price shocks and supply disruptions
  • Import substitution: Strengthening domestic manufacturing of Active Pharmaceutical Ingredients (APIs) to improve trade balance

Keywords: Import substitution · Self-reliance · Production Linked Incentive · Pharmaceutical manufacturing · Supply chain resilience

Read the full news →Report a mistake in this noteHow notes are madeSource: The Hindu ↗Also: GS2 · Government policies & schemes

More Economy notes

All Economy current affairs →

Something wrong, or something missing?

Spotted a mistake in a note, or want a topic, format or PDF that would help your preparation? Write to us. We read every mail and fix errors fast.

Report a mistake →Ask for something →[email protected]

This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.